M3 ( (JP:2413) ) just unveiled an update.
M3, Inc. has disclosed the latest status of its ongoing share repurchase program authorized by its board in May 2026. Between August 1 and August 31, the company bought back 1,116,200 common shares on the Tokyo Stock Exchange for a total of about 2.0 billion yen, under a discretionary trading contract.
The buyback forms part of a broader authorization allowing M3 to repurchase up to 20 million shares, or 3.00% of its outstanding stock, for as much as 20 billion yen during the period from May 2, 2026 to April 30, 2027. The move underscores the company’s active capital management strategy and may support shareholder value by reducing the number of shares in circulation, though the company notes it may ultimately repurchase less than the approved maximum depending on market conditions.
The most recent analyst rating on (JP:2413) stock is a Hold
with a Yen1750.00 price target.
To see the full list of analyst forecasts on M3 stock,
see the JP:2413 Stock Forecast page.
More about M3
M3, Inc. is a Japan-based company listed on the TSE Prime Market under ticker 2413. Headquartered in Tokyo, it operates in the digital healthcare and medical information services sector, focusing on online platforms and solutions for medical professionals and related stakeholders in the healthcare industry.
Average Trading Volume: 4,812,971
Technical Sentiment Signal: Sell
Current Market Cap: Yen1259.7B
For a thorough assessment of 2413 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
This story was written using TipRanks's AI tools and reviewed by a TipRanks editor.